TrialInternational immunopharmacology2020

Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial.

Farzaneh Dastan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.